0001140361-13-021688.txt : 20130517 0001140361-13-021688.hdr.sgml : 20130517 20130517172511 ACCESSION NUMBER: 0001140361-13-021688 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20130515 FILED AS OF DATE: 20130517 DATE AS OF CHANGE: 20130517 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: KIRK THOMAS F CENTRAL INDEX KEY: 0001258258 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-10670 FILM NUMBER: 13856071 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: HANGER, INC. CENTRAL INDEX KEY: 0000722723 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-SPECIALTY OUTPATIENT FACILITIES, NEC [8093] IRS NUMBER: 840904275 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 10910 DOMAIN DRIVE STREET 2: SUITE 300 CITY: AUSTIN STATE: TX ZIP: 78758 BUSINESS PHONE: 512-777-3800 MAIL ADDRESS: STREET 1: 10910 DOMAIN DRIVE STREET 2: SUITE 300 CITY: AUSTIN STATE: TX ZIP: 78758 FORMER COMPANY: FORMER CONFORMED NAME: HANGER ORTHOPEDIC GROUP INC DATE OF NAME CHANGE: 19920703 FORMER COMPANY: FORMER CONFORMED NAME: SEQUEL CORP DATE OF NAME CHANGE: 19890814 FORMER COMPANY: FORMER CONFORMED NAME: CELLTECH COMMUNICATIONS INC DATE OF NAME CHANGE: 19860304 4 1 doc1.xml FORM 4 X0306 4 2013-05-15 0 0000722723 HANGER, INC. HGR 0001258258 KIRK THOMAS F 2616 LIGHTHOUSE BEND DR PONTE VEDRA BEACH FL 32082 1 0 0 0 Common Stock 2013-05-15 4 A 0 5525 0 A 478647 D Common Stock 2013-05-15 4 A 0 1019 32.39 A 479666 D Common Stock 2013-05-15 4 M 0 100000 15.67 A 579666 D Common Stock 2013-05-15 4 F 0 69717 32.28 D 509949 D Option to Buy 15.67 2013-05-15 4 M 0 100000 0 D 2005-01-02 2014-01-02 Common Stock 100000 0 D Option to Buy 8.08 2006-01-03 2015-01-03 Common Stock 100000 100000 D Consists of shares of restricted stock granted under the Company's 2010 Omnibus Incentive Plan (the "Plan"), which vest to the extent of one-third on May 15, 2014 and cumulatively vest to the extent of one-third each year thereafter, subject to certain provisions of the Plan. Consists of shares of restricted stock which the Reporting Person elected to receive in lieu of the annual director fee payable to the Reporting Person. This option vested over a four-year period from the date of grant and is now fully vested. /s/ Jessica Lochmann Allen, Attorney-in-Fact for Thomas F. Kirk 2013-05-17